About Us
Therapeutic Focus
Technology & IP
Pipeline
Commercial
Business Development
News & Media
Contact Us
News & Media
Company Spotlight
Press Releases
Company News
Publications
Events
What is the likelihood of opioid-induced nausea and vomiting (OINV) in patients who by history are assumed to be not at risk of developing OINV?
Abstract not published in abstract book